Drug of Choice for Uncomplicated Cellulitis
For uncomplicated cellulitis, a penicillinase-resistant semisynthetic penicillin or a first-generation cephalosporin (such as cephalexin) is the drug of choice, unless streptococci or staphylococci resistant to these agents are common in the community. 1
Pathogen Considerations
Cellulitis is most commonly caused by:
- β-hemolytic streptococci (primarily Streptococcus pyogenes)
- Staphylococcus aureus (typically methicillin-sensitive)
MRSA is an unusual cause of typical cellulitis. A prospective study demonstrated that treatment with β-lactams was successful in 96% of patients, suggesting that cellulitis due to MRSA is uncommon 1
First-Line Treatment Options
Oral Therapy (for mild to moderate cases):
- Penicillinase-resistant penicillins (dicloxacillin)
- First-generation cephalosporins (cephalexin)
- Amoxicillin-clavulanate
- Clindamycin (for penicillin-allergic patients)
Parenteral Therapy (for severe cases):
- Nafcillin or oxacillin
- Cefazolin
- Clindamycin or vancomycin (for patients with life-threatening penicillin allergies)
Duration of Therapy
- A 5-day course of antimicrobial therapy is as effective as a 10-day course for uncomplicated cellulitis, if clinical improvement has occurred by day 5 1
- Consider extending treatment if the infection has not improved after 5 days 1
Special Considerations
When to Consider MRSA Coverage:
- Cellulitis associated with:
- Penetrating trauma, especially from illicit drug use
- Purulent drainage
- Concurrent evidence of MRSA infection elsewhere
- Nasal colonization with MRSA
- Injection drug use
- Systemic inflammatory response syndrome
MRSA Treatment Options:
- Intravenous: vancomycin, daptomycin, linezolid, or telavancin
- Oral: doxycycline, clindamycin, or trimethoprim-sulfamethoxazole (SMX-TMP)
Combination Therapy:
- If coverage for both streptococci and MRSA is desired for oral therapy:
- Clindamycin alone, or
- SMX-TMP or doxycycline plus a β-lactam (penicillin, cephalexin, or amoxicillin)
Adjunctive Measures
- Elevation of the affected area to promote gravity drainage of edema and inflammatory substances 1
- Treatment of underlying conditions that may predispose to infection (tinea pedis, venous eczema, trauma) 1
- For recurrent cellulitis, consider prophylactic antibiotics (monthly intramuscular benzathine penicillin or oral erythromycin or penicillin V) 1
Common Pitfalls
Overtreatment for MRSA: Unnecessarily covering for MRSA in typical uncomplicated cellulitis can lead to antibiotic overuse and resistance.
Inadequate Duration: Stopping antibiotics too early before clinical improvement is established.
Misdiagnosis: Many conditions mimic cellulitis, including venous stasis dermatitis, contact dermatitis, eczema, and lymphedema 2.
Failure to Elevate: Not elevating the affected area can delay resolution of symptoms.
Missing Underlying Abscess: Failure to identify a deeper abscess that requires drainage in addition to antibiotic therapy.
By following these evidence-based guidelines, clinicians can effectively treat uncomplicated cellulitis while minimizing unnecessary broad-spectrum antibiotic use and optimizing patient outcomes.